The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.2
Gontero, P.
Archivio Italiano di Urologia Andrologia Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 78(4 Suppl. 1): 11-12
2006
ISSN/ISBN: 1124-3562 PMID: 17491550 Document Number: 602939
Document emailed within 1 workday
Related Documents
Victoria Martínez, A.Mercedes.; Sánchez Carazo, Jé.Luis.; Alegre de Miquel, V. 2016: Superficial angiomyxoma of the nipple: a case report of an infrequent cutaneous tumour Dermatology Online Journal 22(10)Yoshida, K.; Takahashi, T.; Nakame, Y.; Saitoh, H.; Horiuchi, S.; Kaneoya, F.; Negishi, T. 1987: Bladder instillation of verapamil as a means of enhancing the efficacy of chemotherapy in superficial bladder carcinoma: influence of bladder instillation of verapamil on the cardiovascular system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(2): 506-510
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Punga-Maole, M.L.; Hubert, J.; Mangin, P. 1995: Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
Kotake, T.; Koyanagi, T.; Akaza, H.; Shimazaki, J.; Ito, H.; Hosaka, M.; Okajima, E.; Saito, Y.; Miyanaga, N.; Kuroda, M.; Hirao, Y. 1998: Results of clinical study with epirubicin hydrochloride injectable solution for superficial bladder cancer. IMI28 Injectable Solution Study Group for Superficial Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(8): 1189-1195
Cockett, A.T.; Merguerian, P.A.; di Sant'Agnese, P.A.; Wheeless, L.L. 1989: Immunotherapy for the treatment of superficial and infiltrative bladder carcinoma Progress in Clinical and Biological Research 303: 455-462
Bandhauer, K.; Bischof, B. 1985: Superficial papillary bladder cancer and carcinoma in situ Helvetica Chirurgica Acta 52(3-4): 467-468
Gruenwald, I.; Stein, A.; Lurie, A. 1995: Conservative treatment of superficial transitional cell carcinoma of the bladder Harefuah 128(2): 104-111
Hisazumi, H.; Ueki, O.; Kumaki, O.; Naito, K.; Misaki, T. 1985: Photodynamic therapy of superficial tumors and carcinoma in situ of the bladder Gan no Rinsho. Japan Journal of Cancer Clinics 31(6 Suppl): 697-703
Werner, W.; Smesny, S.; Schubert, J. 2000: Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 94(6): 519-527
Bouffioux, C. 1985: Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given? Progress in Clinical and Biological Research 185b: 47-55
Unda Urzaiz, M.; Zubiaur Líbano, C.; Pérez Fernández, A.; Iriarte Soldevilla, J.I.; Flores Corral, N. 1990: Adriamycin versus ftorafur in the prevention of recurrence of superficial carcinoma of the bladder Archivos Espanoles de Urologia 43(2): 143-146
Fontana, G.; Caccia, P.; Alladio, F.; Laudi, M.; Pigato, M.; Sesia, G.; Forni, G.; Giovarelli, M. 1989: Interferon-gamma in the treatment of superficial and recurrent bladder carcinoma. Phase one study Progress in Clinical and Biological Research 303: 479-480
Huland, H.; Otto, U. 1983: Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients European Urology 9(2): 84-86
Noguchi, S.; Kubota, Y.; Masuda, M.; Shuin, T.; Yao, M.; Hosaka, M. 1995: Clinical investigation of grade-up superficial bladder cancer Hinyokika Kiyo. Acta Urologica Japonica 41(9): 659-664
Dahse, R.; Utting, M.; Werner, W.; Schimmel, B.; Claussen, U.; Junker, K. 2002: TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples International Journal of Oncology 20(1): 107-115
Chow, N.H.; Tzai, T.S.; Cheng, H.L.; Liu, H.S.; Chan, S.H.; Tong, Y.C. 2000: The clinical value of p21WAF1/CIP1 expression in superficial bladder cancer Anticancer Research 20(2b): 1173-1176
Bach, D.; Romics, I.; Rüssel, C. 1992: Clinical experience with BCG immune prevention in superficial bladder cancer Der Urologe. Ausg. a 31(5): 296-301
Gatti, G.; Zurrida, S.; Gilardi, D.; Bassani, G.; dos Santos, G.Rosali.; Luini, A. 2005: Urinary bladder metastases from breast carcinoma: review of the literature starting from a clinical case Tumori 91(3): 283-286
Huncharek, M.; McGarry, R.; Kupelnick, B. 2001: Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis Anticancer Research 21(1b): 765-769